1 / 6

Liver Diseases Therapeutics Market Research Reports 2015

Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment

Hexareports
Télécharger la présentation

Liver Diseases Therapeutics Market Research Reports 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. www.hexareports.com v Global Liver Diseases Therapeutics Market Size and Share, Growth, Market Price, Analysis, Forecast and Overview 2015 - 2019 Category: Pharmaceutical

  2. Report Overview Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. The liver diseases caused by viral infections,alcoholism, obesity, diabetes, among many other reasons. Some of the diseases are not curable such as liver cirrhosis or non-alcoholic fatty liver disease, and are usually not diagnosed early. This leads to the substantial damage of the liver, which proves to be life-threatening. Some types of hepatitis are preventable or treatable by using vaccinesand indicated drugs. Technavio's analysts forecast the global liver diseases therapeutics market to grow at a CAGR of 15.61% over the period 2014-2019. www.hexareports.com

  3. Covered in this report This report covers the present scenario and the growth prospects of the global liver diseases therapeutics market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of liver diseases. Based Basedon Non-alcoholic fatty liver disease (includes non-alcoholic steatohepatitis) Liver cirrhosis Liver cancer Hepatitis (Hepatitis A, B, and C) ondisease diseaseindication, indication,the themarket marketis issegmented segmentedas as follows follows: : This Thisreport reportincludes Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Easternand African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE includesa a discussion discussionof of the themarket marketin inthe thefollowing followingthree threeregions regions: : APAC APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India. www.hexareports.com

  4. Other prominent vendors AbbVie AchillionPharmaceuticals Advinus Angion Biomedica AstraZeneca Bayer BiOrion Boehringer Ingelheim Bristol-MyersSquibb Celsion Conatus Digna Biotech DynavaxTechnologies Eli Lilly GalectinTherapeutics LG Life Sciences www.hexareports.com

  5. Key market Key Keymarket marketdriver Increasedprevalenceof liverdiseases Fora full,detailedlist,view our report driver Key Keymarket marketchallenge Multiplepatentexpiries Fora full,detailedlist,view our report challenge Key Keymarket markettrend Growingpublicawareness Fora full,detailedlist,view our report trend Key Keyquestions questionsanswered Whatwillthemarketsize be in2019 andwhatwillthegrowthratebe? Whatare the key markettrends? Whatis drivingthismarket? Whatare the challengesto marketgrowth? Who are the key vendorsin thismarketspace? Whatare the marketopportunitiesand threatsfaced by the key vendors? Whatare the strengthsand weaknessesof the key vendors? answeredin inthis thisreport report www.hexareports.com

  6. ThankYou! For MoreDetails http://www.hexareports.com/report/global-liver-diseases-therapeutics- market/details Stay WithUS Global HeadQuarters Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, ‏ United States. E-mail: sales@hexareports.com Telephone Direct : 1-800-489-3075

More Related